當(dāng)前位置：首頁(yè) JCRQ2 期刊介紹(非官網(wǎng))

Journal Of The Chinese Medical AssociationSCIE

國(guó)際簡(jiǎn)稱：J CHIN MED ASSOC 參考譯名：中華醫(yī)學(xué)會(huì)雜志

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：1726-4901; E-ISSN：1728-7731; 是否OA：開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：TAIWAN; 出版商：Elsevier Taiwan LLC; 出版語(yǔ)言：English; 出版周期：Monthly; 出版年份：2003; 研究方向：MEDICINE, GENERAL & INTERNAL

評(píng)價(jià)信息：: 影響因子：1.9; H-index：37; CiteScore指數(shù)：6.2; SJR指數(shù)：0.507; SNIP指數(shù)：0.562

發(fā)文數(shù)據(jù)：: Gold OA文章占比：100.00%; 研究類文章占比：90.78%; 年發(fā)文量：141; 自引率：0.1333...; 開源占比：0.998; 出版撤稿占比：0; 出版國(guó)人文章占比：0.11; OA被引用占比：0.9991...

投稿咨詢加急見刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡(jiǎn)介Journal Of The Chinese Medical Association期刊介紹

Journal of the Chinese Medical Association, previously known as the Chinese Medical Journal (Taipei), has a long history of publishing scientific papers and has continuously made substantial contribution in the understanding and progress of a broad range of biomedical sciences. It is published monthly by Wolters Kluwer Health and indexed in Science Citation Index Expanded (SCIE), MEDLINE?, Index Medicus, EMBASE, CAB Abstracts, Sociedad Iberoamericana de Informacion Cientifica (SIIC) Data Bases, ScienceDirect, Scopus and Global Health.

JCMA is the official and open access journal of the Chinese Medical Association, Taipei, Taiwan, Republic of China and is an international forum for scholarly reports in medicine, surgery, dentistry and basic research in biomedical science. As a vehicle of communication and education among physicians and scientists, the journal is open to the use of diverse methodological approaches. Reports of professional practice will need to demonstrate academic robustness and scientific rigor. Outstanding scholars are invited to give their update reviews on the perspectives of the evidence-based science in the related research field. Article types accepted include review articles, original articles, case reports, brief communications and letters to the editor

期刊簡(jiǎn)介Journal Of The Chinese Medical Association期刊介紹

《Journal Of The Chinese Medical Association》自2003出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：偏慢,4-8周約15.5周
醫(yī)學(xué)
MEDICINE, GENERAL & INTERNAL
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Journal Of The Chinese Medical Association Cite Score數(shù)據(jù)

CiteScore：6.2
SJR：0.507
SNIP：0.562

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：General Medicine	Q1	69 / 636	89%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Journal Of The Chinese Medical Association 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué)：內(nèi)科	4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Journal Of The Chinese Medical Association JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, GENERAL & INTERNAL	SCIE	Q2	104 / 325	68.2%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, GENERAL & INTERNAL	SCIE	Q1	79 / 329	76.14%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
Taiwan470
CHINA MAINLAND70
Turkey24
Iran13
USA11
Japan8
South Korea7
Thailand7
Pakistan5
Australia3

本刊中國(guó)學(xué)者近年發(fā)表論文

1、A novel extraperitoneal approach exploration for the treatment of urachal mass: a retrospective observational single-center study
Author: Sui, Yuanming; Zhang, Zongliang; Zhao, Kai; Zhang, Yulian; Wang, Zhenlin; Zhu, Guanqun; Yang, Han; Li, Xueyu; Wang, Qinglei; Yin, Xinbao; Wang, Ke

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 1, pp. 34-38. DOI: 10.1097/JCMA.0000000000000834
2、Very early activation of cochlear implants: A review of the literature
Author: Coelho, Daniel H.; Shiao, An-Suey; Li, Lieber Po-Hung

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 1, pp. 7-10. DOI: 10.1097/JCMA.0000000000000816
3、The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery
Author: Chen, Meng-Chao; Su, Hsuan-Yu; Su, Yen-Hao; Huang, Kuo-Hung; Fang, Wen-Liang; Lin, Chii-Wann; Chen, Ming-Huang; Chao, Yee; Lo, Su-Shun; Li, Anna Fen-Yau; Wu, Chew-Wun

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 1, pp. 57-64. DOI: 10.1097/JCMA.0000000000000846
4、Necrostatin-1 prevents skeletal muscle ischemia reperfusion injury by regulating Bok-mediated apoptosis
Author: Cao, Yu; Wang, Hong-Bo; Ni, Chun-Jue; Chen, Shun-Li; Wang, Wan-Tie; Wang, Liang-Rong

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 1, pp. 26-33. DOI: 10.1097/JCMA.0000000000000806
5、Bone age assessment: Large-scale comparison of Greulich-Pyle method and Tanner-Whitehouse 3 method for Taiwanese children
Author: Yuh, Yeong-Seng; Chou, Ting Ywan; Tung, Tao-Hsin

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 2, pp. 246-253. DOI: 10.1097/JCMA.0000000000000854
6、Hypoglycemic drug liraglutide alleviates low muscle mass by inhibiting the expression of MuRF1 and MAFbx in diabetic muscle atrophy
Author: Fan, Dongmei; Wang, Yue; Liu, Bowei; Yin, Fuzai

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 2, pp. 166-175. DOI: 10.1097/JCMA.0000000000000807
7、Investigation of preoperative asymptomatic bacteriuria as a risk factor for postvertebroplasty infection
Author: Chen, Kuan-Jung; Huang, Yen-Chun; Yao, Yu-Cheng; Yang, Tzu-Cheng; Lin, Hsi-Hsien; Wang, Shih-Tien; Chang, Ming-Chau; Chou, Po-Hsin

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 2, pp. 233-239. DOI: 10.1097/JCMA.0000000000000852
8、Robot-assisted versus open hepatectomy for liver tumors: Systematic review and meta-analysis
Author: Xue, Qian; Wu, Jianping; Lei, Zehua; Wang, Qing; Fu, Jinqiang; Gao, Fengwei

Journal: JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. 2023; Vol. 86, Issue 3, pp. 282-288. DOI: 10.1097/JCMA.0000000000000870